Main
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
Register:
|
ClinicalTrials.gov |
Last refreshed on:
|
19 February 2015 |
Main ID: |
NCT00257868 |
Date of registration:
|
22/11/2005 |
Prospective Registration:
|
Yes |
Primary sponsor: |
|
Public title:
|
Rivastigmine for the Prevention of Postoperative Delirium in Patients Undergoing Cardiac Surgery
|
Scientific title:
|
Rivastigmine for the Prevention of Postoperative Delirium After Cardiac Surgery |
Date of first enrolment:
|
January 2006 |
Target sample size:
|
120 |
Recruitment status: |
Completed |
URL:
|
http://clinicaltrials.gov/show/NCT00257868 |
Study type:
|
Interventional |
Study design:
|
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double-Blind, Primary Purpose: Prevention
|
Phase:
|
Phase 3
|
|
Countries of recruitment
|
Switzerland
| | | | | | | |
Contacts
|
Name:
|
Luzius A Steiner, MD PhD |
Address:
|
|
Telephone:
|
|
Email:
|
|
Affiliation:
|
Department of Anaesthesia, University Hospital Basel, Switzerland |
| | |
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- Patients undergoing cardiac surgery with use of extracorporeal circulation
- Aged 65 or more
Exclusion Criteria:
- "redo" procedures
- anticipated use of succinylcholine during operation
- contraindications to rivastigmine
- preoperative mini mental score < 15
Age minimum:
65 Years
Age maximum:
N/A
Gender:
Both
|
Health Condition(s) or Problem(s) studied
|
Delirium
|
Intervention(s)
|
Drug: Rivastigmine prevention of delirium
|
Primary Outcome(s)
|
Development of postoperative delirium within 7 days after cardiac surgery
|
Secondary Outcome(s)
|
Length of stay (intensive care and hospital)
|
Severity of delirium occurring within 7 days after cardiac surgery
|
Amount of drugs used for rescue therapy of delirium
|
Secondary ID(s)
|
CENA713CCH01
|
EKBB 204/05
|
Source(s) of Monetary Support
|
Please refer to primary and secondary sponsors
|
Results
|
Results available:
|
|
Date Posted:
|
|
Date Completed:
|
|
URL:
|
|
|
|